Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Preferred Stock Liabilities: 2016

  • Anaptysbio's Preferred Stock Liabilities was N/A to $40.7 million in Q4 2016 from the same period last year, while for Dec 2016 it was $40.7 million, marking a year-over-year change of. This contributed to the annual value of $40.7 million for FY2016, which is N/A change from last year.
  • Latest data reveals that Anaptysbio reported Preferred Stock Liabilities of $40.7 million as of Q4 2016.
  • Anaptysbio's 5-year Preferred Stock Liabilities high stood at $40.7 million for Q4 2016, and its period low was $40.7 million during Q4 2016.
  • For the 1-year period, Anaptysbio's Preferred Stock Liabilities averaged around $40.7 million, with its median value being $40.7 million (2016).